Secondary Amyloidosis Development in a Patient with Juvenile Rheumatoid Arthritis on TNF-alpha Inhibitors Treatment
Journal of Rheumatic Diseases
; : 280-284, 2012.
Article
em Ko
| WPRIM
| ID: wpr-160529
Biblioteca responsável:
WPRO
ABSTRACT
Secondary amyloidosis is one of the most serious complications in chronic inflammatory diseases such as rheumatoid arthritis. The extracellular deposit of aggregates of amyloid leads to target organ dysfunction. The mainstay treatment of secondary amyloidosis is the control of underlying disease activity. Many reports have reported that TNF-alpha inhibitors improve clinical outcomes. Here, we encountered a 34-year-old patient with juvenile rheumatoid arthritis who developed secondary amyloidosis despite treatment with TNF-alpha inhibitors. We present this case and include a review of the literature.
Palavras-chave
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Artrite Juvenil
/
Artrite Reumatoide
/
Fator de Necrose Tumoral alfa
/
Amiloide
/
Amiloidose
Limite:
Adult
/
Humans
Idioma:
Ko
Revista:
Journal of Rheumatic Diseases
Ano de publicação:
2012
Tipo de documento:
Article